CytomX Therapeutics, Inc.

NasdaqGS:CTMX Stock Report

Mkt Cap: US$166.5m

CytomX Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

3.9yrs

Average management tenure


CEO

Sean McCarthy (55 yo)

11.42yrs

Tenure

US$4,339,415

Compensation

Dr. Sean A. McCarthy, D.Phil., serves as Independent Director at OncoResponse, Inc. since July 2021. He has been the Chief Executive Officer of CytomX Therapeutics, Inc. since August 2011 and has been its...


CEO Compensation Analysis

How has Sean McCarthy's remuneration changed compared to CytomX Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$98m

Jun 30 2022n/an/a

-US$97m

Mar 31 2022n/an/a

-US$92m

Dec 31 2021US$4mUS$616k

-US$84m

Sep 30 2021n/an/a

-US$72m

Jun 30 2021n/an/a

-US$64m

Mar 31 2021n/an/a

-US$61m

Dec 31 2020US$3mUS$595k

-US$33m

Sep 30 2020n/an/a

-US$54m

Jun 30 2020n/an/a

-US$63m

Mar 31 2020n/an/a

-US$76m

Dec 31 2019US$4mUS$575k

-US$102m

Sep 30 2019n/an/a

-US$99m

Jun 30 2019n/an/a

-US$99m

Mar 31 2019n/an/a

-US$83m

Dec 31 2018US$5mUS$550k

-US$85m

Sep 30 2018n/an/a

-US$52m

Jun 30 2018n/an/a

-US$39m

Mar 31 2018n/an/a

-US$50m

Dec 31 2017US$3mUS$500k

-US$43m

Sep 30 2017n/an/a

-US$58m

Jun 30 2017n/an/a

-US$62m

Mar 31 2017n/an/a

-US$51m

Dec 31 2016US$3mUS$450k

-US$59m

Compensation vs Market: Sean's total compensation ($USD4.34M) is above average for companies of similar size in the US market ($USD1.63M).

Compensation vs Earnings: Sean's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Sean McCarthy
Chairman & CEO11.42yrsUS$4.34m0.47%
$ 778.9k
Lloyd Rowland
Senior VP4.67yrsUS$1.42m0.032%
$ 53.4k
Christopher Ogden
Senior VP of Finance and Accounting1.42yrsno data0%
$ 0
Chau Cheng
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Danielle Olander-Moghadassian
Senior VP & Chief Human Resources Officerno datano datano data
Leslie Robbins
Senior Vice President of Intellectual Property3.92yrsno datano data
Marcia Belvin
Senior VP & Head of Research2.25yrsno datano data
Jeffrey Landau
Senior VP1.75yrsno data0.033%
$ 55.8k
Jamie Moore
Senior VP & Head of Protein and Process Sciences and Manufacturingno datano datano data
Hoyoung Huh
Special Advisor to Chief Executive Officerno dataUS$273.54kno data

3.9yrs

Average Tenure

53yo

Average Age

Experienced Management: CTMX's management team is considered experienced (3.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sean McCarthy
Chairman & CEO11.42yrsUS$4.34m0.47%
$ 778.9k
Elaine Jones
Independent Director3.67yrsUS$123.85k0.00021%
$ 349.7
John Lambert
Member of Scientific Advisory Board3yrsno datano data
Louis Weiner
Member of Scientific Advisory Boardno datano datano data
Mani Mohindru
Independent Director2.08yrsUS$125.85k0%
$ 0
James Meyers
Independent Director4.08yrsUS$129.85k0%
$ 0
Matthew Young
Lead Independent Director7.33yrsUS$159.85k0%
$ 0
Halley Gilbert
Independent Director2.75yrsUS$135.35k0%
$ 0
W. Kavanaugh
Member of Scientific Advisory Board2.08yrsUS$8.03mno data
Lisa Butterfield
Member of Scientific Advisory Board3yrsno datano data
Charles Sentman
Member of Scientific Advisory Board3yrsno datano data
Lisa Coussens
Member of Scientific Advisory Board3yrsno datano data

3.0yrs

Average Tenure

57yo

Average Age

Experienced Board: CTMX's board of directors are considered experienced (3 years average tenure).